AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy
|
|
- Carmella Higgins
- 5 years ago
- Views:
Transcription
1 AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy Author/Designation Responsible Officer / Designation Kevin Chapman - Tissue Viability - Modern Matron Kevin Chapman - Tissue Viability - Modern Matron Contents Section Description Page No 1 Introduction 1 2 Prescribing of Injectables 1 3 Consent to Treatment 2 4 Equipment 2 5 Mechanical Safety Devices 2 6 Injection Sites 2 7 Patient considerations 3 8 Violence and Aggression considerations Injection under restraint 3 9 Allergic Reaction / Anaphylaxis 4 10 Training Implications 4 11 References 5 Appendices listed separate to PGN Document No: Appendix 1 Description Issue Issue Date Standard operating procedures for preparation and administration of intramuscular injections Review date 1 Sep 2017 Sep 2020 Appendix 2 Anatomical sites 1 Sep 2017 Sep 2020 Appendix 3 Administration of oil-based depot and other long acting intramuscular antipsychotic injections - site poster 1 Sep 2017 Sep 2020 AMPH-PGN-10 Intramuscular Injection (IMI) V01-Iss Sep17
2 1 Introduction 1.1 An Intramuscular Injection (IMI), deposits medication into deep muscle tissue under the subcutaneous tissue where the vascularity of the muscle aids the absorption of the medication. In Intramuscular injection (IMI) the skin is punctured with a needle and medication is administered deep into a large muscle of the body for prophylactic or curative purposes. 1.2 The preparation and administration of an Intramuscular Injection is a medical/nursing procedure that occurs frequently across all clinical and community areas covered by Trust staff on a daily basis. Whilst the reporting and recording of untoward incidents in relation to the administration of IMI within the Trust appears low, anecdotal evidence suggest that clinicians practice a variety of techniques and procedures. 1.3 Poor injection techniques can put the patient at risk of complications such as abscesses, cellulitis, haematoma and injury to blood vessels, bones and peripheral nerves (Cocoman et al 2006). Therefore it is important that a good, unified injection technique be adopted throughout the Trust. 1.4 Much of the procedural content of this document closely follows that which is described in the consensus document Guidance on the administration to Adults of oil-based Depot and other Long-Acting Intramuscular Antipsychotic Injections (5 th Edition, 2016) and Royal Marsden Hospital Manual of Clinical Procedures, 8th edition. This is available on the intranet. 1.5 A number of possible injection sites and techniques are described in this document. 1.6 Competence and capability in the safe and proficient use of intramuscular injections are ultimately an individual practitioner s responsibility. 1.7 This document covers the general principals of good practice in relation to the administration of intramuscular injections, but cannot cover all the detailed requirements of all injectable medicines currently available. 1.8 It is essential that practitioners are familiar with the requirements for administration of medicines as laid out with the product SPC (Summary of Product Characteristics) or PIL (Patient Information Leaflet). Practitioners should only administer medicines within their sphere of competency and specific product requirements. 2 Prescribing of Injectables 2.1 The administering clinician must reference to (UHM-PGN 02 - Part of NTW(C)17 Medicine Policy), checking that the injection is being administered either under a valid prescription or within the authorisation of a Patient Group Directive (PGD). Such a prescription must specify the following: The name of the patient 1
3 The printed name and designation of the prescriber (including signature) The approved medicine name full (i.e Decanoate etc.) The dose The frequency of administration The start / Stop and review date and route of administration 2.2 In addition to this any administration of an IMI under a PGD can be done by a clinician who has been specifically authorised by the PGD. Administration of an IMI under a PDG cannot be delegated to an unauthorised clinician. 3 Consent to Treatment 3.1 Please refer to Appendix 1 for an outline detail of the Mental Capacity Act Consent to Treatment. The Trust policy for consent to examination or treatment should also be consulted. In the case of any patient whose first language is not English staff should also refer to the Trust Policy for the provision of, access to and use of interpreters for patients and carers for further guidance. 4 Equipment 4.1 The area in which the medicine is to be prepared must be clean, uncluttered and free from any interruption/distraction. Once the administering clinician is satisfied that the prescription is valid, prepare administration as per the appropriate standing operating procedures (SOP) and pharmaceutical manufacturers instructions. Appendix 1 5 Mechanical safety devices 5.1 If a device is available the Trust must provide staff administering intramuscular injections with medical devices that incorporate safety-engineered protection mechanisms. 5.2 These devices have a built-in safety feature to reduce the risk of a sharps injury before, during or after use. 5.3 Staff should not only be aware of mechanical safety devices but also be aware of how to respond to an inoculation incident - specific guidance on this is and safe disposal of sharps is available in NTW(C) 46 Inoculation Injury Policy and IPC-PGN-03.1 Safe use and disposal of sharps. You can also seek specific advice and guidance from the IPC Matrons. 6 Injection sites 6.1 At present current research and evidence suggests that there are five sites that can be utilised for the administration of intramuscular injections, and selecting the injection site requires correct identification of the muscle groups by land marking correct anatomical features. For full details staff are to refer to Appendix 2 2
4 6.2 With regard to which injection site to choose, this will be influenced by the patient s physical condition including age weight etc and the licence and instructions from the pharmaceutical manufacturers and where possible the patients individual preference. 6.3 Intramuscular injections should be given into the densest part of the muscle, and an active patient will probably have a greater muscle mass than older or emaciated patients. 7 Patient considerations 7.1 NTW respects the cultural and religious needs of its patient group and will take every step to respect these requirements during the process of providing injectable medication. 7.2 Staff will make every effort to accommodation any specific gender requirements during the exposure of sites and subsequent administration. (i.e. Female to female) 7.3 Staff when considering injection sites for patients under observation by others will choose a site that preserves the dignity of the patient. 7.4 Staff will consider and make reasonable adjustments for any of the following reasons - Physical considerations due to BMI (Making allowances for reduced or increased adipose tissue) - Access and administration requirements such as restrictive clothing, cleansing of the skin etc. 8 Violence and Aggression considerations injection under restraint. Staff should also read this PGN in conjunction with NTW(C) 02 The Management of Rapid Tranquillisation policy and its associated appendices. Staff should ensure a pre-injection briefing takes place ahead of planned administration to ensure the team are familiar with their individual roles and responsibilities. This is to ensure seamless administration, prevent confusion during the process and ensure the intervention is as timely and safe as possible. Staff must consider elements which include - Is physical restraint or coerced injection necessary have all other options been exhausted? Wherever possible implement Talk First principles. - Is it likely that the person will be resistive, in what way? How do we mitigate the risks while using the principle of least restriction? 3
5 - Ensuring staff are communicating clearly to the patient what is happening during the intervention and responding to any complaints of pain or discomfort in a safe manner - Who is leading / co-ordinating the intervention? - Use of safer sharps - Site and administration requirements (see above and Appendix 2) - Access and egress to the administration area, especially if a treatment room is not used. - Safe disposal of sharps (Refer to Waste Management policy) - Recording and incident reporting where applicable - Ensure all staff involved are aware of the person s clinical history, risks, preferences, communication needs and considerations as outlined above - Have the team got legal authority to administer (T3/T62) - How to mitigate obstructions and potential risks in the environment? - Which restraint position is planned and is a contingency plan required in the event of an escalation of risk? - How do we preserve the dignity of the individual during intervention? - Who is responsible for post injection monitoring, and how will this be done? Particularly if the individual continues to present as aggressive in conjunction with seclusion policy etc - To update carers/imha next of kin if applicable - Recording of intervention on RiO and through Safeguard system - Debriefing of patient and staff following incident 9 Allergic reaction / Anaphylaxis 9.1 Allergic reactions and anaphylaxis are emergency conditions which any patient could be potentially at risk of, and it is well documented that the emergency treatment of anaphylaxis is more effective the earlier it is commenced, and may be lifesaving in the first few minutes. Within the Trust training for anaphylaxis is provided as a component of the Immediate Life Support course. 9.2 All in-patient units, and other services where a specific risk of severe allergic reaction has been identified, are required to stock/carry Adrenaline for use by suitably trained staff in an emergency situation. The administration of adrenaline by staff to a person to save life is permissible by law and does not require a prescription. However, if this action is taken, a full record of the incident must be made in the patient clinical records and a web-based electronic reporting form completed. Details of the patients reaction and the need for adrenaline to be administered must be reported to the relevant Consultant at the earliest opportunity, or to the on call Doctor outside of normal working hours. 10 Training Implications 10.1 Training to clinical staff in the administration of intramuscular injections will be provided as follows: 4
6 Staff undertaking IM injections should have completed the relevant Medicines Management competency (MM Comp 3 Management and administration of Intra-Muscular Depot / Injectable Medication) As part of their local induction for any newly appointed staff Updates to staff through peer to peer instruction /supervision As required more formal training can be arranged by the Trust Learning and Development Department by utilising more experienced staff across the Trust 10.2 In addition to this Registered Nurses are required to maintain their own competence and access updates as necessary. 11 REFERENCES Cocoman A and Murray J (2006) IM injections: How s your technique Clinical Practice. DH (2005b) Hazardous waste (England) regulations. Department of Health, London. DH (2005) mental Capacity Act Code of Practice DH (2010) Health and Social Care Act Code of practice on the prevention and control of infections and related guidance. London. Crown Copyright. European Union Council Directive 2010/32/EU. Framework agreement on prevention from sharps injuries in the hospital and healthcare setting. Griffith, R. & Jordan, S. (2003) Administration of medicines part 1: the law and nursing. Nurse Stand, 18(2), Pub Med Mental Capacity Act 2005 Mental Health Act 2007 MHRA (2004) Reducing Needle stick and Sharps Injuries. Medicines and Healthcare Products Regulatory Agency, London. National Institute for Health and Clinical Excellence (2012)- Prevention and control of healthcare associated infections in primary and community care. NICE clinical guideline 139. NMC (2005) Guidelines for Records and Record Keeping. Nursing and Midwifery Council, London. NMC (2006b) A-Z Advice Sheet Consent. NMC (2008a) Standards for Medicines Management, Nursing and Midwifery Council, London. NMC (2008b) The Code: Standards of Conduct, Performance and Ethics for Nurses and Midwives. Nursing and Midwifery Council, London. 5
7 NPSA (2005) Wristbands for Hospital Inpatients Improves Safety) Safer Practice Notice 11). NPSA, London. NPSA (2007) Promoting Safer Use of Injectable Medicines, Alert No. 2007/20, 28th March. NPSA, London. NPSA (2007) Promoting Safer Use of Injectable Medicines, Alert No. 2007/20, 28th March. NPSA, London. Royal Marsden on line 8th edition United Kingdom Psychiatric Pharmacy Group (UKPPG) (2016) Guidance on the Administration to Adults of Oil based Depot and other Long Acting Intramuscular Antipsychotic Injections, 5 th Edition. Workman, B. (1999) Safe injection techniques. Nurse Stand, 13(39), Pub Med. 6
The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services
Standard Operating Procedure 2 (SOP 2) The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services Why we have a procedure? Black Country
More informationDr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure
OLANZAPINE DEPOT PROCEDURE OCTOBER 2017 Policy title Policy reference Policy category Relevant to Date published Implementatio n date Date last reviewed Next review date Policy lead Contact details Accountable
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationGUIDELINES FOR ADMINISTRATION OF MEDICINES BY INTRAMUSCULAR INJECTION. Quality, Safety and Governance Committee Consultation & Approval:
GUIDELINES FOR ADMINISTRATION OF MEDICINES BY INTRAMUSCULAR INJECTION Author: Sponsor/Executive: Responsible committee: Ratified by: Non Medical Prescribing Lead Advanced Clinical Pharmacist Director of
More informationAdministration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure
Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date
More informationPromoting Effective Immunisation Practice
4th Edition 2017 Contents Introduction 3 Who is the programme for? 3 Learning Outcomes 4 Notes for employers 4 Updating 5 Notes for students 6 What are the options for learning? 6 Brief overview of the
More informationSTANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES
STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version One Purpose of Issue/ Description of Change To promote the safe administration
More informationIt is each Integrated CMHT Manager s responsibility to ensure adherence to this procedure.
Date of Next Review: 7 Apr 2019 Previous Trust/LHB Reference Number: N/A Depot Medication Procedure and Protocol for the Administration of Depot Medication in Community Mental Health Teams Reference Number:
More informationOPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1
OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1 Applies to: All employees of Wirral Community NHS Trust Group for Approval Infection Prevention and Control Group Date of Approval 25 January
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationHealth & Social Services
The States of Jersey Department for Health & Social Services AGREED PROCESS FOR COMMUNITY INTRAVENOUS THERAPY Date approved DOCUMENT PROFILE Document Registration Document Purpose Short Title Author Publication
More informationManagement of Reported Medication Errors Policy
Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust
More informationExecutive Director of Nursing and Chief Operating Officer
Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15
More informationSharps Policy Safe Use and Disposal
Sharps Policy Safe Use and Disposal This procedural document supersedes: PAT/IC 8 v.6 Sharps Policy - Safe use and Disposal Did you print this document yourself? The Trust discourages the retention of
More informationADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS
ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS This policy should be read in conjunction with the Syringe Driver Policy and the Medicines Policy Version: 6 Date of Issue:
More informationFOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING
STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration
More informationMartina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist
Policy on Pharmacological Therapies Practice Guidance Note The use of Oral Anti-Cancer Medicines and Oral Methotrexate within - V03 V03 - Issued Issue 1 Dec 15 Planned review December 2018 PPT-PGN 09 Part
More informationMcKinley T34 Ambulatory syringe pump Used in the provision of adult palliative and end of life care
Health Guidance McKinley T34 Ambulatory syringe pump Used in the provision of adult palliative and end of life care Publication Code: HCR-0214-083 Publication date: 26 February 2014 Page 1 of 7 Health
More informationPROCEDURE FOR IMMUNISATION
Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To promote the safe administration of vaccines 2014 Named Responsible Officer:- Approved by Date Medicines Governance
More informationHealthcare Support Workers. Administration of Medicines For Specified Children with Complex Needs in the Community
Healthcare Support Workers Administration of Medicines For Specified Children with Complex Needs in the Community Author: Children s Community Nursing Team Child Health This document in principle matches
More informationAdministration and checking of medicines by Assistant Practitioners
Document level: Trustwide (TW) Code: MP25 Issue number: 1 Administration and checking of medicines by Assistant Practitioners Lead executive Authors details Type of document Target audience Document purpose
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationPatient Self Administration of Intravenous (IV) Antibiotics at Home
Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient
More informationPLASTER CASTS, APPLIANCES OR BRACES
PRESSURE DAMAGE: POLICY FOR PREVENTION IN PATIENTS WITH PLASTER CASTS, APPLIANCES OR BRACES To be read in conjunction with the Pressure Ulceration Policy and DVT and PE Policy Version: 2 Ratified by: Date
More informationNon Attendance (Did Not Attend-DNA ) Policy. Executive Director of Nursing and Chief Operating Officer
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Non Attendance (Did Not Attend-DNA) NTW(C)06 Executive Director of Nursing and Chief Operating Officer Ann Marshall
More informationNON MEDICAL PRESCRIBING POLICY
NON MEDICAL PRESCRIBING POLICY Document Summary This Policy provides the framework and standards for Non-Medical Prescribing. The application of this policy will ensure that all non-medical prescribers
More informationPatient Group Drection (PGD) Number : Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 (Gardasil )
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationDerby Hospitals NHS Foundation Trust. Drug Assessment
Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration
More informationNURSE-LED DISCHARGE POLICY
THE NORTH WEST LONDON HOSPITALS TRUST Name: NURSE-LED DISCHARGE POLICY Communication 1. All staff must be aware of this policy. 2. All first line managers must have read and have a working knowledge of
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationNBCP PO C Administration of injections
POLICY CATEGORY: POLICY FOCUS: POLICY NAME: Administration of injections policy (EN) LAST UPDATED: February 2014 MOTION NUMBER: C-14-02-08 OTHER: GM-PP-I-03 (Supplement to administration of injections
More informationManagement and Administration of Oxygen Competency Assessment. For Registered Nurses Band 5 and above To be completed 3 yearly
MM Comp 5 V02 Issue 2 Ratified MMC - Sept 2016 Issued Mar 18 Review - July 2019 Management and Administration of Oxygen Competency Assessment For Registered Nurses Band 5 and above To be completed 3 yearly
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationMedicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017
Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP to nurses, midwives, healthcare workers, agency staff, contract workers and volunteers by registered nurses and
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationAdult Protocol Intermittent Catheterisation
Adult Protocol Intermittent Catheterisation Page 1 of 8 Policy reference: Continence Introduction Adult Protocol Intermittent Catheterisation This protocol covers management of incomplete bladder emptying
More informationThe School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT
The School Of Nursing And Midwifery. BMedSci Nursing (Adult) CLINICAL SKILLS PASSPORT Student Details NAME: COHORT: I understand that this booklet may be reviewed by my mentor, the programme leader, my
More informationName Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019
PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationDelegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers. Version No.1 Review: November 2019
Livewell Southwest Delegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers Version No.1 Review: November 2019 Notice to staff using a paper copy of this guidance
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationECT Reference: Version 4 Effective Date: 28/02/2017. Date
Chaperone Policy Policy Title: Executive Summary: Chaperone Policy This policy sets out guidance on the use of chaperones within the Trust and is based on recommendations from the General Medical Council,
More informationST PAUL S CATHOLIC PRIMARY SCHOOL AND NURSERY. Supporting Pupils with Medical Conditions Policy
ST PAUL S CATHOLIC PRIMARY SCHOOL AND NURSERY Supporting Pupils with Medical Conditions Policy Our Mission Statement Do everything with love. (St Paul s first letter to the Corinthians 16:14) This means
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationDISTRICT NURSING and INTERMEDIATE CARE
CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above
More informationViolence and Aggression NICE guideline Important implications for practice. Peter Tyrer, Imperial College, London
Violence and Aggression NICE guideline Important implications for practice Peter Tyrer, Imperial College, London Reason for update of 2005 guideline This guideline was felt to be a little too restrictive
More informationSouth Tyneside NHS Foundation Trust. Clinical Policy. Chaperoning Policy. Review Date June 2011
South Tyneside NHS Foundation Trust Clinical Policy Chaperoning Policy Date Approved by Version Issue Date June 2009 2 June Executive 2009 Director of Nursing & Clinical Services Procedure /Policy number
More informationPolicy Checklist. Working Group: Administration of Infusion of Intravenous Fluids & Medicines in Neonates (Chairperson: Dr Hogan) YES
Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side consultation? Policy for the administration
More informationAnaphylactic Reaction Emergency Treatment Reference Number:
This is an official Northern Trust policy and should not be edited in any way Anaphylactic Reaction Emergency Treatment Reference Number: NHSCT/12/551 Target audience: Nursing Staff Groups included are:
More informationProtocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit
Protocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Assurance Sub Group Date ratified: 28
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationGG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Immunisation
More informationPROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS
STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients
More informationNon Medical Prescribing Policy Register No: Status: Public
Non Medical Prescribing Policy Policy Register No: 07049 Status: Public Developed in response to: Department of Health Policies, Prescribing Guidance & Legislation Contributes to CQC Outcome: 9 Consulted
More informationThe Services. Tender for. The Provision of Sub Dermal Contraceptive Implant Devices [Long Acting Reversible Contraception]
The Services Tender for The Provision of Sub Dermal Contraceptive Implant Devices [Long Acting Reversible Contraception] Sexual Health Services Level 2 Reference DN110585 Corporate Development Page 1 of
More informationAdult Protocol Urethral Catheterisation
Adult Protocol Urethral Catheterisation Page 1 of 8 Policy reference: Continence Introduction Adult Protocol Urethral Catheterisation Urethral catheterisation is the insertion of a urinary catheter into
More informationPATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )
PATIENT GROUP DIRECTION Administration of: By: Practice Nurses Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix ) In: General Practice It is the responsibility of the professional working
More informationNon medical prescribing policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope...3
Non medical prescribing policy Board library reference Document author Assured by Review cycle P015 Non medical prescribing lead Quality and Standards Committee 3 years This document is version controlled.
More informationPatient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian
NHS Grampian Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian Lead Author: Consultation Group: Approver: Highly
More informationPolicy for the Reporting and Management of Incidents Including Serious Incidents. Version Number: 006
CONTROLLED DOCUMENT Policy for the Reporting and Management of Incidents Including Serious Incidents CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the principles
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationBernard Olisemeke. Advanced Practitioner Fluoroscopy Modality Lead
Bernard Olisemeke Advanced Practitioner Fluoroscopy Modality Lead What do you do son? Fluoroscopy Services Lead Research & Development Lead Radiographers supply / admin of Med Lead Overview Legislations
More informationGuidelines for In-patient and Residential staff. Staff in Mental Health and Learning Disability In-
Guidelines for In-patient and Residential staff in Mental Health and Learning Disability Services for contacting the On call -Training Grade Doctor/GP DOCUMENT CONTROL Version 4.2 Ratified by Quality and
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationCompetency Framework for the Administration of all Blood Products
Framework for the Administration of all Blood Products Ref No. Authors Others Consulted during preparation Date Created December 2006 Date reviewed March 2007 Date approved Implementation date April 2007
More informationNHS North Somerset Clinical Commissioning Group
NHS North Somerset Clinical Commissioning Group Medicines Policy - Safe and Secure Handling of Medicines Approved by: Quality and Assurance Group Ratification date: July 2013 Review date: June 2016 Page
More informationImmunisation Knowledge and Skills Competence Assessment Tool
Immunisation Knowledge and Skills Competence Assessment Tool Second edition CLINICAL PROFESSIONAL RESOURCE IMMUNISATION KNOWLEDGE AND SKILLS COMPETENCE ASSESSMENT TOOL Acknowledgements This publication
More informationQuality Standards CLINICAL AND QUALITY GOVERNANCE. Version 1.2
Quality s CLINICAL AND QUALITY GOVERNANCE Version 1.2 October 2015 8831 October 2015 West Midlands Quality Review Service These Quality s may be reproduced and used freely by NHS and social care organisations
More informationDirectorate: Medical Due for Review: June Ope Owoso, Medicines Optimisation Pharmacist. Table of Contents
Provider Community Services v 2.0 1923 Title: Injectable Medicines Policy for Registered Professionals Ref No: Version 2.0 Directorate: Medical Due for Review: June 2017 Responsible for review: Ratified
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationNote: 44 NSMHS criteria unmatched
Commonwealth National Standards for Mental Health Services linkage with the: National Safety and Quality Health Service Standards + EQuIP- content of the EQuIPNational* Standards 1 to 15 * Using the information
More informationADMINISTRATION OF INSULIN IN THE COMMUNITY BY SUPPORT WORKERS
Title Purpose ADMINISTRATION OF INSULIN IN THE COMMUNITY BY SUPPORT WORKERS This guideline is to assist: Service Providers (organisations and individuals), Participants, stakeholders and funders regarding
More informationBlood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.
Blood Transfusion Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Clinical The policy describes the framework and principles required to deliver best transfusion
More informationHOSPITAL SERVICES DISCHARGE PLANNING NURSE BAND 6 JOB DESCRIPTION
HOSPITAL SERVICES DISCHARGE PLANNING NURSE BAND 6 JOB DESCRIPTION JOB SUMMARY: It is expected that as a result of general training and experience a Band 6 registered nurse is able to lead in the assessment
More informationCare Coordination and Care Programme Approach Practice Guidance Note Learning Disability Admissions Urgent Care Only V02
Care Coordination and Care Programme Approach Practice Guidance Note Learning Disability Admissions Urgent Care Only V02 Date issued Issue 2 Dec 15 Issue 3 Dec 17 Author/Designation Responsible Officer
More informationNHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)
SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED
More informationHordle CE (VA) Primary School and Nursery
Hordle CE (VA) Primary School and Nursery ADMINISTRATION OF MEDICINES POLICY Headteacher approving this policy - Fiona Adams.. Signature of Headteacher October 2015 Date Chair of Governors approving this
More informationClinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.
Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and
More informationDeputise and take charge of the given area regularly in the absence of the clinical team leader who has 24 hour accountability and responsibility.
JOB DESCRIPTION AND Public Health Nurse School Nurse PERSON SPECIFICATION FOR: AGENDA FOR CHANGE BAND: Band 6 HOURS AND DURATION; As specified in the job advertisement and the Contract of Employment AGENDA
More informationCourse of Study for the Certification of Competence in Administering Intravenous Injections
R A D I O G R A P H Y Course of Study for the Certification of Competence in Administering Intravenous Injections 1 2 Course of Study for the Certification of Competence in Administering Intravenous Injections
More informationPromoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated Click Here
Promoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated 2011 Click Here Promoting Effective Immunisation Practice Published Summer 2011 NHS Education for Scotland
More informationAdministration of Medicines Workbook Year 1
School of Nursing and Health Sciences Administration of Medicines Workbook Year 1 STUDENT S NAME: CLASS/YEAR: SEP 2017 PROGRAMME: BSc Nursing, School of Nursing and Health Sciences. DATE WORKBOOK COMMENCED:
More informationPharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02
Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 V02 issued Issue 1 May 11 Issue 2 Dec 11 Planned review May
More informationClinical Lead. Contract of Employment
JOB DESCRIPTION AND PERSON SPECIFICATION FOR Clinical Lead AGENDA FOR CHANGE BAND Band 7 HOURS AND DURATION As specified in the job advertisement and the Contract of Employment AGENDA FOR CHANGE REF NO
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationSkills Passport. Keep this Skills Passport in your Personal & Professional Development File (PPDF)
Skills Passport - NURSING BSc (Hons) / M Nurs in Nursing Studies / Registered Nurse Skills Passport Student s Name: Cohort: Guidance Tutor Group: Keep this Skills Passport in your Personal & Professional
More informationSupporting Students with Medical Conditions Policy. Beths Grammar School
Supporting Students with Medical Conditions Policy Beths Grammar School 1. Statement of intent... 2 2. Key roles and responsibilities... 2 3. Definitions... 4 4. Training of staff... 5 5. The role of the
More informationStandard Operating Procedure
Standard Operating Procedure Title of Standard Operation Procedure (SOP): Disposal of Medicines No: SS4 Version No:3 Issue Date: June 2017 Review Date: June 2020 Purpose and Background Increasing numbers
More informationAranesp (Darbepoetin) for Renal Anaemia
Aranesp (Darbepoetin) for Renal Anaemia Information for patients, relatives and carers Renal Department York and Scarborough Hospitals Tel: 01904 725370 For more information, please contact: Renal Anaemia
More informationReport. Leigh House, Specialised Services Winchester
Report Leigh House, Specialised Services Winchester Thursday 23 rd February 2012 Overall Impression Leigh house appeared to have a calm and relaxed atmosphere with a non-clinical feel, a nice environment
More informationTHE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS
PGD3717 PATIENT GROUP DIRECTION FOR THESUPPLY OF METRONIDAZOLE 400mg TABLETSFOR THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS (TV) by registered nurses and midwives in Integrated Sexual
More informationPressure Ulcer Policy - Tissue Viability Top Ten
Pressure Ulcer Policy - Tissue Viability Top Ten This procedural document supersedes: PAT/T 3 v.2 Pressure Ulcer Prevention and Management Policy and incorporates PAT/T 4 Guidelines for the Prevention
More informationPromoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated Click Here
Promoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated 2014 Click Here Promoting Effective Immunisation Practice Published Summer 2014 NHS Education for Scotland
More informationVersion: 5. Date Adopted: 17 April Date issued for publication: Review date: October Expiry date: 1 April 2021
The Policy and Procedure for the Administration of Intravenous Medication to Adults and Children within the Community and Community Hospital The document prescribes how clinicians will administer medication
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More information